S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide

S100A4 (metastasin-1), a metastasis-associated protein and marker of the epithelial to mesenchymal transition, contributes to several hallmarks of cancer and has been implicated in the progression of several types of cancer. However, the impacts of S100A4 signaling in lung cancer progression and its...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, Rachel L., Carpenter, Brittany L., West, Dava S., Knifley, Teresa, Liu, Lili, Wang, Chi, Weiss, Heidi L., Gal, Tamas S., Durbin, Eric B., Arnold, Susanne M., O'Connor, Kathleen L., Chen, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085181/
https://www.ncbi.nlm.nih.gov/pubmed/27127879
http://dx.doi.org/10.18632/oncotarget.8969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085181/
https://www.ncbi.nlm.nih.gov/pubmed/27127879
http://dx.doi.org/10.18632/oncotarget.8969

Ejemplares similares